Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma [Hematologic Malignancy]
Conclusion
We have refined our understanding of genetic events in myeloma and identified clinically relevant mutations that may be used to better stratify patients at presentation.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Walker, Boyle, Wardell, Murison, Begum, Dahir, Proszek, Johnson, Kaiser, Melchor, Aronson, Scales, Pawlyn, Mirabella, Jones, Brioli, Mikulasova, Cairns, Gregory, Quartilho, Drayson, Russell, Cook, Jackson, Leleu, Davies, Morgan Tags: Diagnosis & Staging, Biology & Immunology Hematologic Malignancy Source Type: research
More News: Allergy & Immunology | Biology | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Hematology | Molecular Biology | Myeloma | Study